ID   CP2F1_HUMAN             Reviewed;         491 AA.
AC   P24903; A7KAU6; A7KAU7; A7KAU8; A7KAU9; A7KAV0; Q32MN5; Q8WWJ2;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   22-SEP-2009, sequence version 2.
DT   10-MAY-2017, entry version 147.
DE   RecName: Full=Cytochrome P450 2F1;
DE            EC=1.14.14.1 {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816, ECO:0000269|PubMed:8558432};
DE   AltName: Full=CYPIIF1;
GN   Name=CYP2F1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RC   TISSUE=Lung;
RX   PubMed=1974816; DOI=10.1021/bi00475a012;
RA   Nhamburo P.T., Kimura S., McBride O.W., Kozak C.A., Gelboin H.V.,
RA   Gonzalez F.J.;
RT   "The human CYP2F gene subfamily: identification of a cDNA encoding a
RT   new cytochrome P450, cDNA-directed expression, and chromosome
RT   mapping.";
RL   Biochemistry 29:5491-5499(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT HIS-266.
RX   PubMed=11827709; DOI=10.1016/S0027-5107(01)00274-3;
RA   Chen N., Whitehead S.E., Caillat A.W., Gavit K., Isphording D.R.,
RA   Kovacevic D., McCreary M.B., Hoffman S.M.G.;
RT   "Identification and cross-species comparisons of CYP2F subfamily genes
RT   in mammals.";
RL   Mutat. Res. 499:155-161(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES CYP2F1*1; CYP2F1*2A;
RP   CYP2F1*2B; CYP2F1*3; CYP2F1*4; CYP2F1*5A; CYP2F1*5B AND CYP2F1*6).
RX   PubMed=17327131; DOI=10.1016/j.mrfmmm.2007.01.007;
RA   Tournel G., Cauffiez C., Billaut-Laden I., Allorge D., Chevalier D.,
RA   Bonnifet F., Mensier E., Lafitte J.-J., Lhermitte M., Broly F.,
RA   Lo-Guidice J.-M.;
RT   "Molecular analysis of the CYP2F1 gene: identification of a frequent
RT   non-functional allelic variant.";
RL   Mutat. Res. 617:79-89(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=8619884; DOI=10.1016/0006-2952(95)02184-1;
RA   Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Maeenpaeae J.,
RA   Edwards R.J., Boobis A.R., Raunio H.;
RT   "Expression of xenobiotic-metabolizing cytochrome P450 forms in human
RT   full-term placenta.";
RL   Biochem. Pharmacol. 51:403-411(1996).
RN   [7]
RP   CATALYTIC ACTIVITY.
RX   PubMed=8558432;
RA   Thornton-Manning J., Appleton M.L., Gonzalez F.J., Yost G.S.;
RT   "Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes:
RT   correlation of 3-methyleneindolenine formation and protein-binding.";
RL   J. Pharmacol. Exp. Ther. 276:21-29(1996).
RN   [8]
RP   CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10383923;
RA   Lanza D.L., Code E., Crespi C.L., Gonzalez F.J., Yost G.S.;
RT   "Specific dehydrogenation of 3-methylindole and epoxidation of
RT   naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid
RT   cells.";
RL   Drug Metab. Dispos. 27:798-803(1999).
CC   -!- FUNCTION: May be involved in the metabolism of various
CC       pneumotoxicants including naphthalene. Is able to dealkylate
CC       ethoxycoumarin, propoxycoumarin, and pentoxyresorufin but
CC       possesses no activity toward ethoxyresorufin and only trace
CC       dearylation activity toward benzyloxyresorufin. Bioactivates 3-
CC       methylindole (3MI) by dehydrogenation to the putative electrophile
CC       3-methylene-indolenine. {ECO:0000269|PubMed:1974816}.
CC   -!- CATALYTIC ACTIVITY: RH + [reduced NADPH--hemoprotein reductase] +
CC       O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.
CC       {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816,
CC       ECO:0000269|PubMed:8558432}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413; Evidence={ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.018 mM for 3-methylindole {ECO:0000269|PubMed:10383923,
CC         ECO:0000269|PubMed:1974816};
CC         Vmax=51.2 pmol/min/mg enzyme toward ethoxy-coumarin
CC         {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816};
CC         Vmax=24.3 pmol/min/mg enzyme toward propoxy-coumarin
CC         {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816};
CC         Vmax=22 pmol/min/mg enzyme toward pentoxy-resorufin
CC         {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816};
CC         Vmax=2.29 pmol/min/mg enzyme toward benzyloxy-resorufin
CC         {ECO:0000269|PubMed:10383923, ECO:0000269|PubMed:1974816};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:10383923}; Peripheral membrane protein
CC       {ECO:0000305|PubMed:10383923}. Microsome membrane
CC       {ECO:0000269|PubMed:10383923}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:10383923}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P24903-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P24903-2; Sequence=VSP_055575, VSP_055576;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in lung. Rarely detected in liver
CC       and placenta. {ECO:0000269|PubMed:1974816,
CC       ECO:0000269|PubMed:8619884}.
CC   -!- POLYMORPHISM: Eight non disease-associated alleles are known:
CC       CYP2F1*1, CYP2F1*2A, CYP2F1*2B, CYP2F1*3, CYP2F1*4, CYP2F1*5A,
CC       CYP2F1*5B and CYP2F1*6. The sequence shown corresponds to allele
CC       CYP2F1*1.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP2F1 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp2f1.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02906; AAA52156.1; -; mRNA.
DR   EMBL; AF372573; AAL69652.1; -; Genomic_DNA.
DR   EMBL; AF372570; AAL69652.1; JOINED; Genomic_DNA.
DR   EMBL; AF372571; AAL69652.1; JOINED; Genomic_DNA.
DR   EMBL; AF372572; AAL69652.1; JOINED; Genomic_DNA.
DR   EMBL; EF122241; ABO41976.1; -; Genomic_DNA.
DR   EMBL; EF122242; ABO41977.1; -; Genomic_DNA.
DR   EMBL; EF122243; ABO41978.1; -; Genomic_DNA.
DR   EMBL; EF122244; ABO41979.1; -; Genomic_DNA.
DR   EMBL; EF122245; ABO41980.1; -; Genomic_DNA.
DR   EMBL; AC008962; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC109056; AAI09057.1; -; mRNA.
DR   CCDS; CCDS12572.1; -. [P24903-1]
DR   PIR; A36036; A36036.
DR   PIR; B36036; B36036.
DR   RefSeq; NP_000765.2; NM_000774.4. [P24903-1]
DR   UniGene; Hs.558318; -.
DR   UniGene; Hs.676472; -.
DR   ProteinModelPortal; P24903; -.
DR   SMR; P24903; -.
DR   STRING; 9606.ENSP00000333534; -.
DR   iPTMnet; P24903; -.
DR   PhosphoSitePlus; P24903; -.
DR   BioMuta; CYP2F1; -.
DR   DMDM; 259016202; -.
DR   PaxDb; P24903; -.
DR   PRIDE; P24903; -.
DR   Ensembl; ENST00000331105; ENSP00000333534; ENSG00000197446. [P24903-1]
DR   Ensembl; ENST00000532164; ENSP00000471416; ENSG00000197446. [P24903-2]
DR   GeneID; 1572; -.
DR   KEGG; hsa:1572; -.
DR   UCSC; uc002opu.2; human. [P24903-1]
DR   CTD; 1572; -.
DR   DisGeNET; 1572; -.
DR   GeneCards; CYP2F1; -.
DR   H-InvDB; HIX0202929; -.
DR   HGNC; HGNC:2632; CYP2F1.
DR   MIM; 124070; gene.
DR   neXtProt; NX_P24903; -.
DR   OpenTargets; ENSG00000197446; -.
DR   PharmGKB; PA27109; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118775; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; P24903; -.
DR   KO; K07416; -.
DR   OMA; WGEASEI; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P24903; -.
DR   TreeFam; TF352043; -.
DR   Reactome; R-HSA-211935; Fatty acids.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-211999; CYP2E1 reactions.
DR   SABIO-RK; P24903; -.
DR   GeneWiki; CYP2F1; -.
DR   GenomeRNAi; 1572; -.
DR   PRO; PR:P24903; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000197446; -.
DR   CleanEx; HS_CYP2F1; -.
DR   ExpressionAtlas; P24903; baseline and differential.
DR   Genevisible; P24903; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central.
DR   GO; GO:0070330; F:aromatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; TAS:ProtInc.
DR   GO; GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IDA:UniProtKB.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central.
DR   GO; GO:0018931; P:naphthalene metabolic process; IDA:UniProtKB.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   GO; GO:0018979; P:trichloroethylene metabolic process; IEA:Ensembl.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR020469; Cyt_P450_CYP2_fam.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR01957; EP450ICYP2F.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Endoplasmic reticulum; Heme;
KW   Iron; Membrane; Metal-binding; Microsome; Monooxygenase;
KW   Oxidoreductase; Polymorphism; Reference proteome.
FT   CHAIN         1    491       Cytochrome P450 2F1.
FT                                /FTId=PRO_0000051759.
FT   METAL       436    436       Iron (heme axial ligand). {ECO:0000250}.
FT   VAR_SEQ     303    320       VSTTLHHAFLALMKYPKV -> PACRRRSTSWWDARGCRR
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055575.
FT   VAR_SEQ     321    491       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055576.
FT   VARIANT      38     38       S -> P (in allele CYP2F1*4;
FT                                dbSNP:rs58285195).
FT                                /FTId=VAR_058863.
FT   VARIANT      98     98       R -> P (in allele CYP2F1*6;
FT                                dbSNP:rs57670668).
FT                                /FTId=VAR_058864.
FT   VARIANT     218    218       D -> N (in allele CYP2F1*3 and in allele
FT                                CYP2F1*4; dbSNP:rs80319612).
FT                                /FTId=VAR_058865.
FT   VARIANT     266    266       Q -> H (in allele CYP2F1*3;
FT                                dbSNP:rs75405062).
FT                                {ECO:0000269|PubMed:11827709}.
FT                                /FTId=VAR_058866.
FT   VARIANT     391    391       L -> P (in allele CYP2F1*5A and in allele
FT                                CYP2F1*5B; dbSNP:rs144315434).
FT                                /FTId=VAR_058867.
FT   VARIANT     490    490       P -> L (in allele CYP2F1*3;
FT                                dbSNP:rs7246981).
FT                                /FTId=VAR_058868.
FT   CONFLICT    156    157       EL -> DV (in Ref. 1; AAA52156).
FT                                {ECO:0000305}.
FT   CONFLICT    219    219       I -> ILDPR (in Ref. 1; AAA52156 and 2;
FT                                AAL69652). {ECO:0000305}.
FT   CONFLICT    256    259       Missing (in Ref. 1; AAA52156).
FT                                {ECO:0000305}.
FT   CONFLICT    440    440       S -> L (in Ref. 1; AAA52156).
FT                                {ECO:0000305}.
SQ   SEQUENCE   491 AA;  55501 MW;  D8022271FC0B6D06 CRC64;
     MDSISTAILL LLLALVCLLL TLSSRDKGKL PPGPRPLSIL GNLLLLCSQD MLTSLTKLSK
     EYGSMYTVHL GPRRVVVLSG YQAVKEALVD QGEEFSGRGD YPAFFNFTKG NGIAFSSGDR
     WKVLRQFSIQ ILRNFGMGKR SIEERILEEG SFLLAELRKT EGEPFDPTFV LSRSVSNIIC
     SVLFGSRFDY DDERLLTIIR LINDNFQIMS SPWGELYDIF PSLLDWVPGP HQRIFQNFKC
     LRDLIAHSVH DHQASLDPRS PRDFIQCFLT KMAEEKEDPL SHFHMDTLLM TTHNLLFGGT
     KTVSTTLHHA FLALMKYPKV QARVQEEIDL VVGRARLPAL KDRAAMPYTD AVIHEVQRFA
     DIIPMNLPHR VTRDTAFRGF LIPKGTDVIT LLNTVHYDPS QFLTPQEFNP EHFLDANQSF
     KKSPAFMPFS AGRRLCLGES LARMELFLYL TAILQSFSLQ PLGAPEDIDL TPLSSGLGNL
     PRPFQLCLRP R
//
